Actively Recruiting
Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Led by Hôpital NOVO · Updated on 2026-03-31
346
Participants Needed
9
Research Sites
80 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to validate a French version of the Nasal Reconstruction FACE-Q questionnaire for patients who have undergone nasal reconstruction or prosthetic rehabilitation after surgery for nasal skin cancer. The questionnaire evaluates appearance, quality of life, and possible side effects related to the reconstruction. The investigators hypothesize that the validated French version will provide a reliable and standardized tool to assess patient satisfaction and health-related quality of life in this context.
CONDITIONS
Official Title
Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Patients who had excision of nasal skin cancer with surgical reconstruction using a flap or prosthetic rehabilitation more than 4 months ago and less than 3 years ago with stable results
- Patients informed about the study and not opposed to participating
- Control subjects aged 65 years or older
- Control subjects informed and not opposed to participating
- Control subjects without history of facial trauma or surgery and without major comorbidities such as moderate or severe heart failure, recent heart attack, severe chronic respiratory disease, uncontrolled diabetes, active immunosuppressive diseases, severe facial dermatological conditions, or other serious comorbidities affecting quality of life or respiratory function
You will not qualify if you...
- Patients under anticoagulant or antiplatelet therapy
- Non-French-speaking patients
- Patients under legal protection or with limited legal capacity
- Patients unlikely to cooperate or with poor expected compliance, including psychiatric disorders other than depression or cognitive impairment
- Pregnant or breastfeeding women
- Non-English-speaking control subjects
- Control subjects under guardianship or legal protection, legally incompetent or with limited legal capacity
- Control subjects unlikely to cooperate or with low expected cooperation, including psychiatric disorders other than depression or cognitive disorders
- Pregnant or breastfeeding control subjects
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
CHU Caen
Caen, France, 14000
Not Yet Recruiting
2
Centre Antoine Lacassagne
Nice, France, 06000
Actively Recruiting
3
Institut Curie
Paris, France, 75005
Not Yet Recruiting
4
Hôpital Lariboisière (AP-HP)
Paris, France, 75010
Not Yet Recruiting
5
Hôpital Bichat (APHP)
Paris, France, 75018
Not Yet Recruiting
6
Hopital Novo
Pontoise, France, 95300
Actively Recruiting
7
HNIA Toulon
Toulon, France, 83000
Actively Recruiting
8
CHU Toulouse
Toulouse, France, 31400
Not Yet Recruiting
9
Institut Gustave Roussy
Villejuif, France, 94800
Not Yet Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here